Page 85 - EJMO-9-2

Eurasian Journal of
Medicine and Oncology Gut microbiota and hyperuricemia: Mechanisms and therapeutic strategies

2012;54(1):90-96. doi: 10.1056/NEJMra0904569
doi: 10.1097/MPG.0b013e318229da1a 126. Teng H, Wang Y, Sui X, et al. Gut microbiota-mediated
122. Vergalito F, Pietrangelo L, Petronio Petronio G, et al. nucleotide synthesis attenuates the response to neoadjuvant
Vitamin E for prevention of biofilm-caused healthcare- chemoradiotherapy in rectal cancer. Cancer Cell.
associated infections. Open Med (Wars). 2019;15:14-21. 2023;41(1):124-138.e6.
doi: 10.1515/med-2020-0004 doi: 10.1016/j.ccell.2022.11.013
123. Khanna D, Fitzgerald JD, Khanna PP, et al. 2012 American 127. Wang L, Ye J. Commentary: Gut microbiota reduce the risk
College of Rheumatology guidelines for management of gout. of hyperuricemia and gout in the human body. Acta Pharm
Part 1: Systematic nonpharmacologic and pharmacologic Sin B. 2024;14(1):433-435.
therapeutic approaches to hyperuricemia. Arthritis Care Res
(Hoboken). 2012;64(10):1431-1446. doi: 10.1016/j.apsb.2023.11.013
128. Wan Y, Wong OWH, Tun HM, et al. Fecal microbial marker
doi: 10.1002/acr.21772
panel for aiding diagnosis of autism spectrum disorders. Gut
124. Pascart T, Richette P. Investigational drugs for hyperuricemia, Microbes. 2024;16(1):2418984.
an update on recent developments. Expert Opin Investig
Drugs. 2018;27(5):437-444. doi: 10.1080/19490976.2024.2418984
doi: 10.1080/13543784.2018.1471133 129. Wang Q, Liang J, Zou Q, et al. Tryptophan metabolism-
regulating probiotics alleviate hyperuricemia by protecting
125. Howard SC, Jones DP, Pui CH. The tumor lysis the gut barrier integrity and enhancing colonic uric acid
syndrome [published correction appears in N Engl J
Med. 2018;379(11):1094]. N Engl J Med. 2011;364(19): excretion. J Agric Food Chem. 2024;72(48):26746-26761.
1844-1854. doi: 10.1021/acs.jafc.4c07716

Volume 9 Issue 2 (2025) 77 doi: 10.36922/ejmo.8579